Renal Cell Carcinoma (RCC)
Also known as: RCC, Renal Cell Cancer / RCC (Renal Cell Carinoma) / RCC / RCC (Renal Cell Carcinoma) / Carcinoma Renal Cell / Renal Cell Adenocarcinoma / Renal-cell Cancer / Carcinoma Renal Cells / Carcinoma, Renal Cell / Renal Cancer Cell / Renal Cell Carcinoma(RCC) / Adenocarcinoma, Renal Cell / Renal Cell Cancer / Cancer, Renal Cell / Renal Cell Carcinoma / Adenocarcinoma of kidney / Renal cell carcinoma stage unspecified / Grawitz tumor / Renal cell carcinoma NOS / Grawitz tumour / Renal cell carcinoma (disorder) / Renal cell carcinoma (morphologic abnormality) / Clear cell carcinoma of kidney (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB15463 | Belzutifan | An inhibitor of hypoxia-inducible factor 2α used as an antineoplastic in the treatment of certain cancers associated with von Hippel-Lindau (VHL) disease. |
DB05258 | Interferon alfa | An immunomodulator used to treat hepatitis B and C as well as certain types of cancer including cutaneous T-cell lymphoma and renal cell carcinoma. |
DB09037 | Pembrolizumab | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. |
DB01268 | Sunitinib | A receptor tyrosine kinase inhibitor and chemotherapeutic agent used for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST). |
DB11800 | Tivozanib | A kinase inhibitor to treat adult patients with renal cell carcinoma (RCC) who have failed prior systemic therapies or experienced relapsed disease. |